| Record ID | ia:organicchemistry0000silv |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/organicchemistry0000silv/organicchemistry0000silv_marc.xml |
| Download MARC binary | https://www.archive.org/download/organicchemistry0000silv/organicchemistry0000silv_meta.mrc |
LEADER: 05363cam 2201285 a 4500
001 ocm25049710
003 OCoLC
005 20201025002114.0
008 911219s1992 caua b 001 0 eng
010 $a 91047041
040 $aDNLM/DLC$beng$cDLC$dNLM$dUKM$dLVB$dNLGGC$dBTCTA$dYDXCP$dHEBIS$dCDX$dOCLCQ$dZWZ$dDEBSZ$dOCLCQ$dDEBBG$dSCB$dGBVCP$dOCLCF$dBEDGE$dNLE$dOCLCO$dOCLCQ$dCOH$dOCLCQ$dKKX$dOCLCO$dOCLCQ$dDHA$dOCLCA$dAPUMS$dOCLCQ$dCCH$dCPO$dOCLCA$dOCLCQ$dBGU$dOCLCO$dOCLCQ$dOCLCO$dDCHUA$dIEUOL$dOCLCO$dBUF$dOCLCO$dOCLCQ$dUKBTH$dL2U$dOCLCA
015 $aGB9251584$2bnb
015 $aGB92Z1889$2bnb
016 7 $a9200064$2DNLM
016 7 $a012-64373$2Uk
019 $a25095807$a26505536$a55495452$a877335795$a1167144108
020 $a0126437300$q(hardcover ;$qacid-free paper)
020 $a9780126437300$q(hardcover ;$qacid-free paper)
035 $a(OCoLC)25049710$z(OCoLC)25095807$z(OCoLC)26505536$z(OCoLC)55495452$z(OCoLC)877335795$z(OCoLC)1167144108
050 00 $aRS403$b.S55 1992
060 00 $aQV 744$bS587o 1992
080 0 $a615.205
082 00 $a615/.19$220
084 $a35.59$2bcl
084 $a44.38$2bcl
084 $a44.42$2bcl
084 $aVS 5350$2rvk
084 $aCHE 893f$2stub
084 $aMED 960f$2stub
084 $aMED 970f$2stub
100 1 $aSilverman, Richard B.
245 14 $aThe organic chemistry of drug design and drug action /$cRichard B. Silverman.
260 $aSan Diego :$bAcademic Press,$c©1992.
300 $axiv, 422 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aDrug discovery, design, and development -- Receptors -- Enzymes (catalytic receptors) -- Enzyme inhibition and inactivation -- DNA and DNA -interactive agents -- Drug metabolism -- Prodrugs and drug delivery systems.
520 $aOffering a new approach to the teaching of medicinal knowledge, this book emphasizes the use of the principles of physical organic chemistry as a basis for drug design. It discusses organic reaction mechanisms of clinically important drugs with mechanistic schemes.
650 0 $aPharmaceutical chemistry.
650 0 $aBioorganic chemistry.
650 0 $aMolecular pharmacology.
650 0 $aDrugs$xDesign.
650 1 $aBioorganic chemistry.
650 3 $aDrugs$xDesign.
650 6 $aChimie pharmaceutique.
650 6 $aChimie bio-organique.
650 6 $aPharmacologie moléculaire.
650 6 $aMédicaments$xConception.
650 6 $aChimie organique.
650 7 $a44.38 pharmacology (medicine)$0(NL-LeOCL)077596536$2bcl
650 7 $a35.59 heterocyclic compounds.$0(NL-LeOCL)077596056$2bcl
650 7 $aMédicaments.$2eclas
650 7 $aChimie organique.$2eclas
650 7 $aPharmacologie.$2eclas
650 7 $aBioorganic chemistry.$2fast$0(OCoLC)fst00832648
650 7 $aDrugs$xDesign.$2fast$0(OCoLC)fst00898790
650 7 $aMolecular pharmacology.$2fast$0(OCoLC)fst01024822
650 7 $aPharmaceutical chemistry.$2fast$0(OCoLC)fst01060115
650 7 $aChimie organique.$2fmesh
650 7 $aChimie pharmaceutique.$2fmesh
650 7 $aConception de médicament.$2fmesh
650 7 $aPharmacocinétique.$2fmesh
650 7 $aArzneimitteldesign$2gnd
650 7 $aArzneimittelentwicklung$2gnd
650 7 $aMolekularpharmakologie$2gnd
650 7 $aNaturstoffchemie$2gnd
650 7 $aPharmakokinetik$2gnd
650 7 $aPharmazeutische Chemie$2gnd
650 17 $aGeneesmiddelen.$2gtt
650 17 $aFarmacochemie.$2gtt
650 17 $aFarmacologie.$2gtt
650 7 $aComposés organiques$xSynthèse.$2ram
650 7 $aPharmacologie moléculaire.$2ram
650 7 $aMédicaments.$2ram
650 7 $aIndustrie pharmaceutique.$2ram
650 7 $aChimie bioorganique.$2ram
650 7 $aChimie pharmaceutique.$2ram
650 7 $aChimie organique.$2ram
650 7 $aFormes pharmaceutiques.$2ram
650 7 $aOrganic chemistry.$2sears
650 07 $aPharmazeutische Chemie.$2swd
650 2 $aChemistry, Organic.
650 2 $aChemistry, Pharmaceutical.
650 2 $aDrug Design.
650 2 $aPharmacokinetics.
653 0 $aDrugs$aDesign
776 08 $iOnline version:$aSilverman, Richard B.$tOrganic chemistry of drug design and drug action.$dSan Diego : Academic Press, ©1992$w(OCoLC)645813872
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/els032/91047041.html
856 41 $3Table of contents$uhttp://www.gbv.de/dms/bowker/toc/9780126437300.pdf
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/description/els032/91047041.html
938 $aBaker and Taylor$bBTCP$n91047041
938 $aCoutts Information Services$bCOUT$n1078795
938 $aYBP Library Services$bYANK$n60049
029 1 $aAU@$b000008667167
029 1 $aAU@$b000050561181
029 1 $aCDX$b1078795
029 1 $aDEBBG$bBV005851907
029 1 $aDEBSZ$b030500923
029 1 $aGBVCP$b016105109
029 1 $aGEBAY$b1766333
029 1 $aHEBIS$b113896107
029 1 $aNLGGC$b089458443
029 1 $aNLM$b9200064
029 1 $aNZ1$b4083645
029 1 $aNZ1$b553415
029 1 $aYDXCP$b60049
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 483 OTHER HOLDINGS